Skip to content

The effect of Nigella Sativa on diabetic neuropathy

Comparison of the efficacy of topical Nigella Sativa product and gabapentin capsule on diabetic peripheral neuropathy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160221026684N2
Enrollment
120
Registered
2022-02-22
Start date
2020-04-20
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic neuropathy. Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified

Interventions

Intervention 1: First intervention group: topical Nigella Sativa product. This product is prepared from aqueous extract of black seed and base cream in the form of 10% ointment, used twice a day (morn

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Type 2 diabetes mellitus with diabetic neuropathy diagnosed by neurologist resident of Yazd controlled glucose (HbA1c less than 9)

Exclusion criteria

Exclusion criteria: Spinal Disorders and Discopathy Heart disorder Renal disorder Liver disorder Active foot ulcer Autoimmune diseases mental illnesses Drug and alcohol addiction Skin diseases in the area of drug use Severe foot vascular disorders

Design outcomes

Primary

MeasureTime frame
Severity of peripheral neuropathy. Timepoint: before intervention and 2, 4 , 8 weeks after intervention. Method of measurement: MICHIGAN NEUROPATHY SCREENING INSTRUMENT.

Secondary

MeasureTime frame
HbA1c. Timepoint: before intervention and 8 weeks after intervention. Method of measurement: Chromatography (HPLC).

Countries

Iran (Islamic Republic of)

Contacts

Public Contactseyedalikhodaie

Yazd University of Medical Sciences

dr.seyedalikhodaie@yahoo.com+98 35 3728 0215

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026